KOLQ Plus Tablet is a combination medication containing Chlorpheniramine Maleate (2mg), Paracetamol (500mg), and Phenylephrine (10mg), formulated to provide effective relief from symptoms associated with common cold, allergic rhinitis, and upper respiratory tract infections. Chlorpheniramine Maleate, an antihistamine, alleviates allergic symptoms such as sneezing, runny nose, and watery eyes by blocking histamine H1 receptors. Paracetamol acts as an analgesic and antipyretic, reducing fever and relieving mild to moderate pain including headaches, muscle aches, and sore throat discomfort. Phenylephrine, a selective alpha-1 adrenergic receptor agonist, serves as a nasal decongestant by constricting blood vessels in the nasal mucosa, thereby reducing nasal congestion and improving breathing. This combination provides a multi-symptom approach, addressing both inflammatory and congestive components of cold and allergy-related conditions. KOLQ Plus is indicated for adults and children above 12 years of age, with dosage and duration to be determined by a healthcare professional based on individual patient needs. Caution is advised in patients with hypertension, cardiovascular disorders, or hepatic impairment. It is contraindicated in individuals hypersensitive to any component. Use under medical supervision is recommended to avoid potential drug interactions and adverse effects.